These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25579842)

  • 1. RSK1 activation promotes invasion in nodular melanoma.
    Salhi A; Farhadian JA; Giles KM; Vega-Saenz de Miera E; Silva IP; Bourque C; Yeh K; Chhangawala S; Wang J; Ye F; Zhang DY; Hernando-Monge E; Houvras Y; Osman I
    Am J Pathol; 2015 Mar; 185(3):704-16. PubMed ID: 25579842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An siRNA screen identifies RSK1 as a key modulator of lung cancer metastasis.
    Lara R; Mauri FA; Taylor H; Derua R; Shia A; Gray C; Nicols A; Shiner RJ; Schofield E; Bates PA; Waelkens E; Dallman M; Lamb J; Zicha D; Downward J; Seckl MJ; Pardo OE
    Oncogene; 2011 Aug; 30(32):3513-21. PubMed ID: 21423205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of p90 ribosomal S6-kinase-1 in oltipraz-induced specific phosphorylation of CCAAT/enhancer binding protein-beta for GSTA2 gene transactivation.
    Lee SJ; Kim SG
    Mol Pharmacol; 2006 Jan; 69(1):385-96. PubMed ID: 16246908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RSK1 drives p27Kip1 phosphorylation at T198 to promote RhoA inhibition and increase cell motility.
    Larrea MD; Hong F; Wander SA; da Silva TG; Helfman D; Lannigan D; Smith JA; Slingerland JM
    Proc Natl Acad Sci U S A; 2009 Jun; 106(23):9268-73. PubMed ID: 19470470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RSK1 promotes murine breast cancer growth and metastasis.
    Czaplinska D; Gorska M; Mieczkowski K; Peszynska-Sularz G; Zaczek AJ; Romanska HM; Sadej R
    Folia Histochem Cytobiol; 2018; 56(1):11-20. PubMed ID: 29498411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced beta-catenin expression in the cytoplasm of advanced-stage superficial spreading malignant melanoma.
    Maelandsmo GM; Holm R; Nesland JM; Fodstad Ø; Flørenes VA
    Clin Cancer Res; 2003 Aug; 9(9):3383-8. PubMed ID: 12960126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutive RAC activation is not sufficient to initiate melanocyte neoplasia but accelerates malignant progression.
    Dalton LE; Kamarashev J; Barinaga-Rementeria Ramirez I; White G; Malliri A; Hurlstone A
    J Invest Dermatol; 2013 Jun; 133(6):1572-81. PubMed ID: 23337888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Clinical Implications of RSK1-3 in Human Breast Cancer.
    Zhao H; Martin TA; Davies EL; Ruge F; Yu H; Zhang Y; Teng XU; Jiang WG
    Anticancer Res; 2016 Mar; 36(3):1267-74. PubMed ID: 26977024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritoneal and hematogenous metastases of ovarian cancer cells are both controlled by the p90RSK through a self-reinforcing cell autonomous mechanism.
    Torchiaro E; Lorenzato A; Olivero M; Valdembri D; Gagliardi PA; Gai M; Erriquez J; Serini G; Di Renzo MF
    Oncotarget; 2016 Jan; 7(1):712-28. PubMed ID: 26625210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Abl and Arg are activated in human primary melanomas, promote melanoma cell invasion via distinct pathways, and drive metastatic progression.
    Ganguly SS; Fiore LS; Sims JT; Friend JW; Srinivasan D; Thacker MA; Cibull ML; Wang C; Novak M; Kaetzel DM; Plattner R
    Oncogene; 2012 Apr; 31(14):1804-16. PubMed ID: 21892207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD271 Down-Regulation Promotes Melanoma Progression and Invasion in Three-Dimensional Models and in Zebrafish.
    Saltari A; Truzzi F; Quadri M; Lotti R; Palazzo E; Grisendi G; Tiso N; Marconi A; Pincelli C
    J Invest Dermatol; 2016 Oct; 136(10):2049-2058. PubMed ID: 27328305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superficial spreading and nodular melanoma are distinct biological entities: a challenge to the linear progression model.
    Greenwald HS; Friedman EB; Osman I
    Melanoma Res; 2012 Feb; 22(1):1-8. PubMed ID: 22108608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein expression of the cell-cycle inhibitor p27Kip1 in malignant melanoma: inverse correlation with disease-free survival.
    Flørenes VA; Maelandsmo GM; Kerbel RS; Slingerland JM; Nesland JM; Holm R
    Am J Pathol; 1998 Jul; 153(1):305-12. PubMed ID: 9665492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p90 ribosomal S6 kinase 1 (RSK1) isoenzyme specifically regulates cytokinesis progression.
    Nam HJ; Lee IJ; Jang S; Bae CD; Kwak SJ; Lee JH
    Cell Signal; 2014 Feb; 26(2):208-19. PubMed ID: 24269382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of detection of superficial spreading and nodular-type melanoma: a multicenter Italian study.
    Carli P; De Giorgi V; Palli D; Maurichi A; Mulas P; Orlandi C; Imberti G; Stanganelli I; Soma P; Dioguardi D; Catricalá C; Betti R; Paoli S; Bottoni U; Lo Scocco G; Scalvenzi M; Giannotti B
    Dermatol Surg; 2004 Nov; 30(11):1371-5; discussion 1375-6. PubMed ID: 15522016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stable overexpression of Smad7 in human melanoma cells inhibits their tumorigenicity in vitro and in vivo.
    Javelaud D; Delmas V; Möller M; Sextius P; André J; Menashi S; Larue L; Mauviel A
    Oncogene; 2005 Nov; 24(51):7624-9. PubMed ID: 16007121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in chromosomal aberrations between nodular and superficial spreading malignant melanoma detected by interphase cytogenetics.
    Poetsch M; Woenckhaus C; Dittberner T; Pambor M; Lorenz G; Herrmann FH
    Lab Invest; 1998 Jul; 78(7):883-8. PubMed ID: 9690566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SOX10 expression in superficial spreading and nodular malignant melanomas.
    Agnarsdóttir M; Sooman L; Bolander A; Strömberg S; Rexhepaj E; Bergqvist M; Ponten F; Gallagher W; Lennartsson J; Ekman S; Uhlen M; Hedstrand H
    Melanoma Res; 2010 Dec; 20(6):468-78. PubMed ID: 20890226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
    J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p90 RSK-1 associates with and inhibits neuronal nitric oxide synthase.
    Song T; Sugimoto K; Ihara H; Mizutani A; Hatano N; Kume K; Kambe T; Yamaguchi F; Tokuda M; Watanabe Y
    Biochem J; 2007 Jan; 401(2):391-8. PubMed ID: 16984226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.